Computer assessment of alternative rubella vaccination strategies in New Zealand
- PMID: 6572834
Computer assessment of alternative rubella vaccination strategies in New Zealand
Abstract
Results from a dynamic computer model of rubella vaccination programmes indicate that consideration should be given to vaccinating all one-year-old girls and boys and revaccinating all girls at about 11 years of age, as well as continuing with the programme for susceptible women in the childbearing age group. With vaccine-induced immunity decaying at about 1% annually, the vaccination of 80 to 95% of all one-year-olds, 95% of 11 year old girls, and 5% of women aged 15 to 33 annually is expected to reduce congenital rubella syndrome deformities to less than 5% of the 1980 incidence by 1994, and to negligible levels thereafter. In comparison, continuation of the present scheme may reduce deformities to only 69% of 1980 levels by 1994 with a slow decline to 25% in 2010. (The 1980 levels used were computer generated to eliminate short-term fluctuations, and do not apply to actual figures from that year.) For convenience and better compliance, measles vaccine and the initial rubella vaccine may be given in combined form at 15 months without altering the effect of either. The rate of decay of immunity after vaccination is critically important in congenital rubella syndrome prediction, so that further accurate monitoring of immune status and congenital rubella incidence is essential.
Similar articles
-
Rubella immunity in 14-18 year old females: assessment in a city practice.N Z Med J. 1987 May 27;100(824):320-2. N Z Med J. 1987. PMID: 3451092
-
Can we prevent an increase in the incidence of congenital rubella syndrome in the next decade?Can Med Assoc J. 1981 Jul 1;125(1):37-40. Can Med Assoc J. 1981. PMID: 7260807 Free PMC article.
-
The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.Commun Dis Rep CDR Rev. 1997 Feb 7;7(2):R26-32. Commun Dis Rep CDR Rev. 1997. PMID: 9046126
-
Control of rubella and congenital rubella syndrome (CRS) in developing countries, Part 2: Vaccination against rubella.Bull World Health Organ. 1997;75(1):69-80. Bull World Health Organ. 1997. PMID: 9141752 Free PMC article. Review.
-
[Vaccination calendar and new risks of infection].Ann Med Interne (Paris). 1998 Oct;149(6):379-84. Ann Med Interne (Paris). 1998. PMID: 9853048 Review. French.
Cited by
-
Synthesis of Evidence to Characterize National Measles and Rubella Exposure and Immunization Histories.Risk Anal. 2016 Jul;36(7):1427-58. doi: 10.1111/risa.12454. Epub 2015 Aug 6. Risk Anal. 2016. PMID: 26249328 Free PMC article.
-
Rubella vaccination.Eur J Pediatr. 1988 Aug;147(6):570-3. doi: 10.1007/BF00442464. Eur J Pediatr. 1988. PMID: 3053188 Review.
MeSH terms
Substances
LinkOut - more resources
Medical